Qualis Innovations, Inc. (QLIS) Research

Qualis Innovations, Inc. (QLIS) specializes in the creation, manufacturing, and distribution of solutions primarily targeting pain management and other disorders affecting the central nervous system (CNS). The company's flagship product is SOLACE, an advanced, non-invasive medical device. SOLACE functions by employing electromagnetic induction to produce therapeutic deep heat beneath the skin's surface, thereby alleviating and reducing pain. Qualis Innovations, Inc. maintains its corporate headquarters in Chadds Ford, Pennsylvania.

Market snapshot

Symbol
QLIS
Price
$0.27
Day change
0.00%
Market cap
$36.4M
P/E ratio
-288.90x
52-week range
0.2601-0.9449
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Bloom Health Partners Inc. (BLMHF)
  • China Infrastructure Construction Corp. (CHNC)
  • CLS Holdings USA, Inc. (CLSH)
  • CloudMD Software & Services Inc. (DOCRF)
  • Deltex Medical Group plc (DTXMF)
  • Fire & Flower Holdings Corp. (FFLWF)
  • Rhinomed Limited (RHNMF)
  • SQI Diagnostics Inc. (SQIDF)

Open Qualis Innovations, Inc. (QLIS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.